The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCap-xx Regulatory News (CPX)

Share Price Information for Cap-xx (CPX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.0825
Bid: 0.08
Ask: 0.085
Change: 0.005 (6.45%)
Spread: 0.005 (6.25%)
Open: 0.0775
High: 0.0825
Low: 0.0775
Prev. Close: 0.0775
CPX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Pre-close Trading Update and Notice of Results

2 Aug 2023 07:00

RNS Number : 9772H
CAP-XX Limited
02 August 2023
 

Dissemination of a Regulatory Announcement that contains inside information for the purposes of Regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310.

 

2 August 2023

CAP-XX Limited

("CAP-XX" or "the Company")

 

Pre-close Trading Update and Notice of results

 

CAP-XX Limited, a world leader in the design and manufacture of thin, prismatic supercapacitors and energy management systems, announces a pre-close trading update in respect of the financial year ended 30 June 2023.

Revenue is expected to be A$4m and adjusted EBITDA* is expected to be (A$1.2m) after excluding A$2.2m in exceptional items relating to legal expenses and provisions for patent protection litigation, and executive severance charges. Year-end cash reserves were A$2.6m including the proceeds of the capital raise which took place in May 2023. Revenue for the second half of FY2023 was impacted by some orders anticipated to be shipped in June 2023 being delayed to Q1 of FY2024.

Quarterly sales improved throughout the financial year but at a level slightly lower than originally expected. An increased focus on strengthening the relationship and focus on the customer is expected to see revenue and sales opportunities continue to grow into FY2024.

The sales pipeline reporting is being reviewed to improve the accuracy, reliability and insight of known opportunities. This new approach is being supported by a modest investment in sales reporting software. The ongoing aim is to establish an updated sales structure which will increase the CAP-XX footprint in the majority of global regions. This will include servicing emerging markets such as India and Southern Africa, whilst increasing coverage in the known markets of Europe and the USA. CAP-XX is also increasing its interaction with the electronic component distributor Digikey which will give CAP-XX an improved interface with new customers.

Before the end of the current calendar year, CAP-XX will present its new product roadmap which includes the 3V version, DMH as well as a surface mountable device (SMD) version. Furthermore, CAP-XX is developing evaluation boards which will assist customers and internal sales during the design-in phase.

Although the market remains relatively volatile, with ongoing geo-political impacts coupled with economic headwinds such as inflation and the energy crisis, the Board looks forward to the 2023/24 financial year with confidence. This expectation is supported by a broadly based increase in orders across the product portfolio and a notable strengthening of the book-to-bill ratio in the past three months.

CAP-XX Chief Executive Officer, Lars Stegmann said "The implementation of our new sales strategy is already raising our local geographic footprint in key markets, improving our customer service levels and project management. I am encouraged that this tailored approach will see a further strengthening of our distribution partner base in the short term and support our objective to profitably build the CAP-XX revenue base in the near term."

The above results are subject to clearance by CAP-XX's independent auditors with the Company's results for the year ended 30 June 2023 expected to be released on 29 September 2023.

* Adjusted EBITDA excludes legal expenses associated with patent infringement and licensing actions and the severance payments and placement fees for the ex/new CEO.

 

For further information contact:

CAP-XX Limited

Pat Elliott (Chairman)

Lars Stegmann (CEO)

 

+61 (0) 2 9428 0139

Kreab (Financial PR)

Robert Speed

 

+44 (0) 20 7074 1800

Allenby Capital (Nominated Adviser and Joint Broker)

David Hart / Piers Shimwell (Corporate Finance)

Tony Quirke/Stefano Aquilino (Sales and Corporate Broking)

 

+44 (0) 20 3328 5656

Cenkos Securities plc (Joint Broker)

Neil McDonald / Pearl Kellie

 

+44 (0) 13 1220 6939

 

More information is available at www.cap-xx.com

 

Notes to Editors:

 

CAP-XX (LSE:CPX) is a world leader in the design and manufacture of ultra-thin prismatic and compact cylindrical supercapacitors. Its prismatic supercapacitors are manufactured in Australia and Malaysia and its cylindrical supercapacitors are manufactured in China. The company's strong intellectual property (IP) portfolio includes 11 patent families. CAP-XX's ultra-thin prismatic supercapacitors are ideal for space-constrained electronics applications where small energy storage device size and thickness are important. The unique feature of CAP-XX supercapacitors is their very high-power density and high-energy storage capacity in space-efficient thin prismatic and compact cylindrical packages. For more information, visit https://www.cap-xx.com/ or email sales@cap-xx.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTPBMRTMTTMBJJ
Date   Source Headline
22nd Dec 202011:00 amRNSPrice Monitoring Extension
22nd Dec 20207:00 amRNSProduct shipped from new production lines
18th Dec 20207:00 amRNSHolding(s) in Company
10th Dec 20208:02 amRNSExercise of employee share options
30th Nov 20207:00 amRNSHolding(s) in Company
25th Nov 20208:15 amRNSResult of AGM and Chairman’s AGM statement
3rd Nov 202012:49 pmRNSReplacement: Audited results
3rd Nov 20207:00 amRNSAudited results for the year ended 30 June 2020
23rd Oct 20207:00 amRNSNotice of Results
8th Oct 20207:00 amRNSAward of LSE Green Economy Mark
10th Sep 20207:11 amRNSCorporate update
26th Aug 20208:23 amRNSHolding(s) in Company
25th Aug 202010:21 amRNSIssue of Shares
21st Aug 20204:41 pmRNSSecond Price Monitoring Extn
21st Aug 20204:36 pmRNSPrice Monitoring Extension
21st Aug 202011:05 amRNSSecond Price Monitoring Extn
21st Aug 202011:00 amRNSPrice Monitoring Extension
17th Aug 20207:35 amRNSHolding(s) in Company
7th Aug 20203:18 pmRNSIoxus intellectual property judgement
26th Jun 20207:28 amRNSIssue of Shares and Director/PDMR Shareholdings
24th Jun 20208:57 amRNSChange of Auditor
19th May 20207:00 amRNSTrading Update
29th Apr 20202:06 pmRNSSecond Price Monitoring Extn
29th Apr 20202:01 pmRNSPrice Monitoring Extension
16th Mar 20207:00 amRNSInterim Results
4th Mar 20207:00 amRNSNotification of date of interim results and update
7th Jan 20207:00 amRNSHolding(s) in Company
6th Jan 20208:22 amRNSHolding(s) in Company
30th Dec 20198:30 amRNSResult of General Meeting
24th Dec 20197:00 amRNSResult of Offer to Qualifying Participants
29th Nov 20199:57 amRNSReplacement: Proposed Acquisition and Fundraising
29th Nov 20197:00 amRNSProposed Acquisition from Murata and Fundraising
28th Nov 20198:53 amRNSResult of AGM
13th Nov 20197:00 amRNSNotice of AGM
8th Nov 20197:00 amRNSAudited results for the year ended 30 June 2019
11th Sep 20197:00 amRNSHolding(s) in Company
31st Jul 20198:48 amRNSHolding(s) in Company
2nd Jul 20197:00 amRNSUS court action settlement and licence agreement
25th Jun 201910:45 amRNSIssue of Shares and Director/PDMR Shareholdings
7th Jun 20198:59 amRNSHolding(s) in Company
6th Jun 20199:03 amRNSTrading Update
30th May 20198:27 amRNSHolding(s) in Company
17th Apr 20193:09 pmRNSHolding(s) in Company
16th Apr 20197:00 amRNSTrading Update
6th Mar 20197:00 amRNSInterim Results
1st Mar 20197:36 amRNSDirector Disclosure Update
22nd Jan 20198:32 amRNSHolding(s) in Company
20th Dec 20188:43 amRNSIssue of Shares and Director/PDMR Shareholdings
20th Nov 20188:29 amRNSResult of AGM and Chairman's AGM statement
14th Nov 20187:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.